The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2024
TeleCleft: Development and Evaluation of a Mobile Application for Monitoring Cleft Patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carvalho Livian Isabel de Medeiros, Araújo Eduarda Gomes Onofre de, de Souza Breno Estevam Silva, Martins Hélder Domiciano Dantas, Tanikawa Daniela Yukie Sakai, Valença Ana Maria Gondim, Mélo Cláudia Batista, de Lucena Edson Hilan Gomes, Lacerda Rosa Helena Wanderley, Bonan Paulo Rogério Ferreti
Аннотация
ObjectiveDevelopment and evaluation of a mobile application for remote monitoring and guidance of pediatric patients diagnosed with cleft lip and/or palate (CL ± P) and their caregivers.DesignThis is a pilot cross-sectional, applied, and quantitative study.SettingThe study was conducted in two tertiary care treatment centers in Brazil.ParticipantsThe participants included 20 caregivers and infants undergoing treatment with nasoalveolar molding (NAM) for CL ± P.InterventionsThe intervention involved using the TeleCleft mobile application for remote monitoring and guidance of caregivers and infants during NAM treatment.Main Outcome Measure(s)The main outcome measures included usability and satisfaction of users with the TeleCleft application.ResultsThe results showed high usability and satisfaction ratings among users of the TeleCleft application. Most participants found remote monitoring to be effective and expressed positive opinions about its convenience and usefulness.ConclusionTeleCleft could be a viable tool for remote monitoring and guidance, reducing the need for patients and caregivers to travel to treatment centers, which could potentially alleviate the burden of care faced by families during the journey of CL ± P treatment.